Agilon Health Inc.

NYSE: AGL · Real-Time Price · USD
1.11
0.05 (4.72%)
At close: Aug 15, 2025, 3:59 PM
1.10
-1.35%
After-hours: Aug 15, 2025, 07:53 PM EDT

Agilon Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.39B 1.53B 1.52B 1.45B 1.48B 1.6B 1.06B 1.22B 1.15B 1.14B 689.77M 694.86M 670.13M 653.45M 462.89M 458.61M 498.96M 413.1M
Cost of Revenue
1.45B 1.48B 1.57B 1.52B 1.46B 1.54B 1.16B 1.19B 1.09B 1.06B 1.92B 668.95M 636.22M 610.98M 462M 443.66M 476.18M 384.01M
Gross Profit
-52.43M 50.72M -44.75M -64.17M 26.27M 69.24M -99.6M 30.48M 57.19M 77.3M -1.23B 25.91M 33.91M 42.46M 887K 14.96M 22.78M 29.09M
Operating Income
-116.03M -22.11M -108.1M -133.51M -42.48M -4.76M -164.3M -48.97M -29.82M 15.92M -63.28M -29.52M -21.05M 1.53M -57.76M -35.6M -298.36M -12.12M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-104.31M -1.69M -104.67M -117.02M -30.25M 3.11M -166.87M -30.27M -15.72M 14.2M -55.94M -29.94M -20.46M 655K -57.25M -36.74M -296.89M -13.72M
Net Income
-104.37M 12.11M -105.79M -117.61M -30.68M 2.7M -182.88M -31.44M -16.75M 16.02M -56.05M -30.67M -21.04M 726K -57.07M -35.84M -298.85M -15.08M
Selling & General & Admin
56.28M 65.96M 59.76M 63.12M 68.74M 74.01M 64.7M 74.14M 81.5M 66.66M 75.21M 51.98M 51.92M 39.83M 53.84M 46.64M 317.56M 37.78M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
7.32M 6.88M 10.09M 6.22M n/a n/a n/a 5.69M 15.69M 4.19M n/a 4.89M 3.04M 3.37M n/a -269K 2.97M 3.43M
Operating Expenses
63.6M 72.83M 69.84M 69.34M 68.74M 74.01M 64.7M 79.45M 87.01M 70.85M 75.21M 55.43M 54.97M 43.21M 53.84M 50.56M 321.14M 41.2M
Interest Expense
1.57M 1.51M 1.57M 1.62M 1.7M 1.28M 1.99M 1.62M 1.55M 1.49M 1.71M 1M 945K 871K 840K 867K 1.5M 2.94M
Selling & Marketing Expenses
n/a n/a n/a n/a -868K -2.42M 1.42M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.51B 1.55B 1.63B 1.58B 1.53B 1.61B 1.22B 1.26B 1.18B 1.13B 1.99B 724.38M 691.19M 654.19M 515.84M 494.21M 797.32M 425.22M
Income Tax Expense
62K 196K 1.76M -590K 417K -133K 267K 1.21M 1.07M -1.76M 107K 559K 580K -71K -179K 256K 435K 16K
Shares Outstanding (Basic)
413.84M 412.94M 412.04M 411.59M 411.27M 408.94M 406.48M 405.79M 410.34M 413.14M 412.1M 411.06M 407.34M 424.06M 372.93M 391.23M 377.44M 325.66M
Shares Outstanding (Diluted)
413.84M 412.94M 412.04M 411.59M 411.27M 408.94M 406.48M 405.79M 410.34M 426.59M 412.1M 411.06M 407.34M 424.06M 372.93M 391.23M 377.44M 325.66M
EPS (Basic)
-0.25 0.03 -0.26 -0.29 -0.07 0.01 -0.45 -0.08 -0.04 0.04 -0.14 -0.07 -0.05 0.00 -0.15 -0.09 -0.79 -0.05
EPS (Diluted)
-0.25 0.03 -0.26 -0.29 -0.07 0.01 -0.45 -0.08 -0.04 0.04 -0.14 -0.07 -0.05 0.00 -0.15 -0.09 -0.79 -0.05
EBITDA
-95.42M 6.7M -96.61M -112.43M -22.64M 1.08M -160.14M -23.31M -8.62M 4.79M -50.33M -25.49M -16.47M 4.9M -52.77M -31.93M -291.78M -7.3M
EBIT
-102.74M -177K -103.1M -118.64M -28.55M 4.4M -160.78M -28.62M -14.13M 9.69M -54.23M -28.94M -19.51M 1.53M -56.41M -35.87M -295.4M -10.78M
Depreciation & Amortization
7.32M 6.88M 6.49M 6.22M 5.91M 5.84M 4.74M 5.31M 5.51M 4.19M 3.91M 3.45M 3.04M 3.37M 3.64M 3.94M 3.61M 3.48M